Joel Greenblatt Alnylam Pharmaceuticals, Inc. Transaction History
Gotham Asset Management, LLC
- $9.41 Billion
- Q3 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 17,575 shares of ALNY stock, worth $4.11 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
17,575
Previous 13,237
32.77%
Holding current value
$4.11 Million
Previous $3.22 Million
50.31%
% of portfolio
0.05%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding ALNY
# of Institutions
643Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$3.86 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$2.95 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.23 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.23 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.16 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $28.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...